In our study, western blot analyses of MDA-MB-231 and HCC1806 breast cancer cells CSCs showed that Gomisin M2 downregulates the Wnt/β-catenin self-renewal pathway and cyclin D1 expression via GSK3β activation. The gene discussed is GSK3B; the disease is breast cancer.